Related Experiment Video

Updated: May 3, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K

Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis?

Akshay Anand1, Neel K Sharma1, Ramandeep Singh2

  • 11] Neuroscience Researh Lab, Department of Neurology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India [2].

Scientific Reports
|February 19, 2014
PubMed

Insights

Levels of the anti-apoptotic receptor Decoy Receptor 1 (DcR1) were significantly lower in patients with age-related macular degeneration (AMD). This finding suggests DcR1 may be a new therapeutic target for AMD.

Area of Science:

  • Ophthalmology
  • Immunology
  • Oncology

Background:

  • A link between age-related degenerative diseases and cancer is suggested.
  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) targets cancer cells via apoptosis.
  • TRAIL interacts with pro-apoptotic and anti-apoptotic receptors, including Decoy Receptor 1 (DcR1).

Purpose of the Study:

  • To investigate the levels of the anti-apoptotic receptor DcR1 in patients with age-related macular degeneration (AMD).
  • To compare DcR1 levels between AMD patients and healthy controls.
  • To explore the role of DcR1 in AMD pathology and its potential as a therapeutic target.

Main Methods:

  • Serum samples from 115 AMD patients (Dry and Wet AMD subtypes) and 61 healthy controls were analyzed.
  • DcR1 levels were quantified using Enzyme-Linked Immunosorbent Assay (ELISA) after normalization with total protein.
  • Statistical analysis was performed using the Mann Whitney U-statistic.

Main Results:

  • Serum DcR1 levels were significantly lower in AMD patients compared to healthy controls (p = 0.001).
  • No significant difference in DcR1 levels was observed between the Wet AMD and Dry AMD subtypes.
  • The findings indicate a potential association between reduced DcR1 levels and AMD pathogenesis.

Conclusions:

  • The study identifies significantly lower DcR1 levels in AMD patients, suggesting its involvement in the disease.
  • DcR1 presents a potential novel therapeutic target for managing age-related macular degeneration.
  • Further research is warranted to elucidate the precise mechanisms of DcR1 in AMD.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.4K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.1K

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K